Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodies

Sandra Heskamp(Radboud University Nijmegen), Hanneke W.M. van Laarhoven(Radboud University Nijmegen)
International Journal of Cancer
January 21, 2013
10.1002/ijc.28046
Cited by 55

Related Papers

ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
|Journal of Nuclear Medicine|2010|92
CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor model
|Theranostics|2026|1